Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.'s share was trading at $571.21 as of March 12th. IDXX’s trailing and forward P/E were 45.91 and 42.02 . respectively according to Yahoo Finance.

Photo by Karlo Tottoc on Unsplash

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. IDXX is positioned to benefit from long-term growth in pet healthcare spending, driven by rising demand for veterinary diagnostics as pet owners increasingly seek advanced care for their animals.

The company’s diagnostic business is highly profitable, supported by recurring revenue and strong margins, making it a durable growth platform. IDXX has consistently demonstrated robust financial performance, with earnings per share growth ranking in the top 10% of all companies over recent quarters and years.

This strength was reflected in November 2025 when the company reported earnings that significantly exceeded Wall Street estimates and raised its full-year guidance, propelling its shares to an all-time high. The aging cohort of pets born during the 2020 pandemic puppy boom adds a structural tailwind, as these animals will require more frequent veterinary visits and diagnostic testing, while pet owners continue to spend more per animal.

IDXX’s share price has mirrored its operational success, gaining 60.4% over the past 52 weeks and placing it among the top 10% of stocks on a relative strength basis. This combination of sustained revenue growth, recurring high-margin diagnostics, and a large, expanding addressable market underpins a bullish investment case.

With its resilient business model, strong financial track record, and favorable demographic trends in pet ownership, Idexx Laboratories offers investors an attractive opportunity to capture both growth and consistent profitability in the pet healthcare sector. The company’s outlook remains positive, making its shares a compelling buy for investors seeking exposure to structural growth in veterinary diagnostics.

Previously, we covered a bullish thesis on IDEXX Laboratories, Inc. (IDXX) by Hidden Market Gems in March 2025, which highlighted the company’s high-margin diagnostic business, recurring revenue, and growth in companion animal, livestock, and water testing markets. IDXX’s stock price has appreciated by approximately 33.87% since our coverage. @MoneyShow shares a similar view but emphasizes the pandemic puppy boom boosting veterinary visits and diagnostics demand.

IDEXX Laboratories, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 58 hedge fund portfolios held IDXX at the end of the fourth quarter which was 55 in the previous quarter. While we acknowledge the risk and potential of IDXX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IDXX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years

Disclosure: None.